Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
01/2000
01/05/2000CN1240449A Substituted phenylketoenols and their use as pesticides and herbicides
01/05/2000CN1048019C Hydrolytically stable pentaerythritol
01/05/2000CN1048018C Phosphonic diester derivative
01/05/2000CN1048017C Novel phosphonocarboxylate compounds and pharmaceutical compositions containing same
01/04/2000US6011172 Preparing alkali metal salts and/or alkaline earth metal salts of alkylphosphinic acids and dialkylphosphinic acids by reacting alkyl halides with phosphorus and alkali or alkaline earth metal hydroxides
01/04/2000US6011168 Process for the preparation[2-((8,9)-dioxo-2,6-diazabicyclo[5.2.0]-non-1(7)-en-2-yl)ethy l]phosphonic acid
01/04/2000US6011099 Oxidation-stabilized polyamide molding materials
01/04/2000US6011034 Insecticidal dihydrooxadiazine compounds
01/04/2000US6011029 Benzodiazepine compounds
01/04/2000US6011021 Glutamate-derived hydroxyphosphinyl derivative.
12/1999
12/30/1999DE19828799A1 Fractionation of lecithin by alcohol extraction to obtain extract with increased phosphatidylcholine content
12/30/1999DE19828419A1 Direct preparation of vinylphosphonic acid and esters useful as comonomers in adhesive or flame-retardant plastics production
12/29/1999WO1999067619A2 Compounds and methods for detecting biomolecules
12/29/1999WO1999067259A1 Method for producing vinyl phosphonic acid compounds
12/29/1999WO1999067258A1 Arylsulfonanilide phosphates
12/29/1999WO1999067244A1 7-alkyl- and cycloalkyl-substituted imidazotriazinones
12/29/1999WO1999067228A1 Fluorophenyl resin compounds
12/29/1999EP0967217A2 Reagents and methods for solid phase synthesis and display
12/29/1999EP0966555A1 Inhibiting ferrous metal corrosion by aqueous ammoniate solutions
12/29/1999EP0966490A2 Catalyst compositions for the polymerization of olefins
12/29/1999EP0966476A1 Quinazolinone compounds
12/29/1999EP0966475A1 Preparation of phosphonium compounds as intermediates for glycine antagonists
12/29/1999EP0966467A1 Annulated azole derivatives useful as microbicidal agents
12/29/1999EP0966447A1 Small molecules useful in the treatment of inflammatory disease
12/29/1999EP0966436A1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
12/29/1999EP0966427A1 Preparation of acid amides and metallisation of compounds
12/29/1999EP0938477A4 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
12/29/1999CN1239964A Tetraphosphonate bicyclic trisanhydrides
12/29/1999CN1239944A New pentaerythritol derivatives, their production, and use and intermdiates for their synthesis
12/29/1999CN1239894A Inositol polyphosphate derivatives and method of using same
12/29/1999CN1047778C Pyrimido [5,4-d] pyrimidines, drugs containing these compounds, their use and process for preparing them
12/29/1999CA2717107A1 Compounds and methods for detecting biomolecules
12/29/1999CA2335760A1 Fluorophenyl resin compounds
12/29/1999CA2335559A1 Arylsulfonanilide phosphates
12/29/1999CA2335193A1 7-alkyl- and cycloalkyl-substituted imidazotriazinones
12/28/1999US6008417 Oxidative dehydroxylation, oxidative cleaving, intramolecular aldol condensation, silylation, c3-chain lengthening and simultaneous saponification, reaction with vinylmagnesium bromide, deprotection, and wittig reaction
12/28/1999US6008398 Non-nucleotide phosphorus ester oligomers
12/28/1999US6008378 Synthetic molecules that specifically react with target sequences
12/28/1999US6008300 Terpolymers of tetrafluoroethylene, perfluoro(alkyl vinyl ether), and ethylenically unsaturated cure site monomer with a pentavalent phosphorus oxide bisphenol-type crosslinking agent of given formula; resistance to hot water
12/28/1999US6008205 Polyisoprenyl phosphate stable analogs for regulation of neutrophil responses
12/28/1999US6008008 Esculetin derivatives
12/28/1999US6007819 Administering to mammal an antigen and a dipeptide-derivative to induce immunoglobulin g immune response; vaccines
12/28/1999CA2001715C Carbocyclic nucleosides and nucleotides
12/23/1999WO1999066005A1 Novel chemiluminescent labeling compounds
12/23/1999WO1999065870A2 Sulfonamide inhibitors of aspartyl protease
12/23/1999WO1999065606A1 Catalyst comprising a complex of a metal of subgroup viii based on a phosphinite ligand, and a method for hydroformylation
12/23/1999WO1999065525A1 Ocular tension lowering agents and phosphoric ester derivatives
12/23/1999DE19827640A1 New imidazotriazine derivatives useful as smooth muscle relaxants for treating e.g. cardiovascular disorders, cerebrovascular disorders, or erectile dysfunction
12/23/1999DE19827232A1 Katalysator, umfassend einen Komplex eines Metalls der VIII. Nebengruppe auf Basis eines Phosphinitliganden und Verfahren zur Hydroformylierung und Hydrocyanierung Catalyst comprising a complex of a metal of the VIII. Subgroup on the basis of a phosphinite and process for the hydroformylation and hydrocyanation
12/23/1999CA2301120A1 Novel chemiluminescent labeling compounds
12/22/1999EP0965268A1 Thermostabilization, osmoprotection, and protection against desiccation of enzymes, cell components and cells by di-glycerol-phosphate
12/22/1999EP0635018B1 4-(1H-2-METHYLIMIDAZO[4,5-c]PYRIDINYLMETHYL)PHENYLSULPHONAMIDE DERIVATIVES AS ANTAGONISTS OF PAF
12/22/1999CN1239473A Method of preparing amino carboxylic acids
12/22/1999CN1047597C Chiral phosphine aminate-metal coordinate compound, prepn. method thereof and application in asymmetrically catalytic hydrogenation
12/21/1999US6005151 Reacting haloaromatic compound with olefin compound using palladium complex catalyst
12/21/1999US6005140 Using a noble metal oxidation catalyst
12/21/1999US6005127 Antimony/Lewis base adducts for Sb-ion implantation and formation of antimonide films
12/21/1999US6005096 For oligonucleotides that are modified to enhance the binding affinity and to bear detectable labels; for diagnostic use
12/21/1999US6005093 Conmpounds used as replacements for one or more complementary nucleoside bases in probes; enable photoactive crosslinking of nucleic acid strands in hybridization assays and therapeutic applications
12/21/1999US6005083 Substituted metal chelating compounds for imaging and therapy
12/21/1999US6004946 Administering 2-(hydroxyphosphinylmethyl)-pentanedioic acid derivatives; treating nervous system disorders
12/21/1999CA2080834C Mono, bis or tris(2,2'-substituted bipyridine) complexes of a metal selected amongst iron, ruthenium, osmium or vanadium and preparation methods thereof
12/21/1999CA2002252C Lubricant compositions
12/21/1999CA1340860C Chemiluminescent fused polycyclic ring-containing 1,2-dioxetanes and assays in which they are used
12/21/1999CA1340856C N-phosphonylmethoxyalkyl pyrimidines and purines and therapeutic application thereof
12/16/1999WO1999064426A1 Heterobicyclic and tricyclic nitric oxide synthase inhibitors
12/16/1999WO1999064417A2 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
12/16/1999WO1999064392A1 Benzamidine derivative
12/16/1999WO1999064155A1 Catalyst comprising a complex of a metal from subgroup viii based on a bidentate phosphonite ligand, and method for producing nitriles
12/16/1999WO1999063995A1 Isoflavone derivatives
12/16/1999WO1999063931A2 Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor
12/16/1999WO1999054280B1 Cubane derivatives as metabotropic glutamate receptor antagonists and process for their preparation
12/16/1999DE19826211A1 Preparation of phosphinic and phosphonic acid derivatives potentially useful as herbicides or as antiviral or antibacterial agents
12/16/1999CA2334812A1 Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor
12/16/1999CA2334476A1 Benzamidine derivative
12/16/1999CA2333691A1 Heterobicyclic and tricyclic nitric oxide synthase inhibitors
12/16/1999CA2333332A1 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
12/15/1999EP0963350A1 Treatment of a formaldehyde-containing waste stream
12/15/1999EP0894116B1 Oxidation-stabilised polyamide moulding materials
12/15/1999EP0873343A4 Metal complex source reagents for chemical vapor deposition
12/15/1999EP0820481B1 Organosilicone having a carboxyl functional group thereon
12/15/1999EP0793647B1 Amphiphilic compounds with at least two hydrophilic and at least two hydrophobic groups based on di, oligo or polyolethers
12/15/1999EP0792252B1 Monomers and composition which can be crosslinked and crosslinked polymers
12/15/1999EP0775147B1 Transesterification process
12/15/1999EP0765332B1 Process for removing waste pox alendronate and its by-products
12/15/1999EP0685457B1 Glycerol derivative, device and pharmaceutical composition
12/15/1999CN1238340A Process (1) for extracting high-purity raw powder of acephate from raw oil of acephate
12/15/1999CN1047387C Semiantigen compound, synthesizing process and use thereof
12/14/1999US6002044 Reacting a lithium or magneisium, a halide and a boronate precursor obtained in a firsst similar step using a boride; adding an oniium halide to the metal borate; purity
12/14/1999US6002029 Antiviral prodrugs
12/14/1999US6002018 N-substituted 4-hydroxyindoline derivatives
12/14/1999US6002006 1(2H) quinoline carboxylic acid derivatives, method for preparing same, and use thereof for synthesizing substances having antibiotic properties
12/14/1999US6001982 Synthesis of oligonucleotides
12/14/1999US6001832 [1,2,4]triazolo[4,3-a]quinoxalinone derivatives, their preparation and use
12/14/1999US6001783 Oil additives for antiwear
12/14/1999US6001782 Oil additives for extreme pressure lubricants
12/14/1999US6001659 Assays using chemiluminescent electron-rich aryl-substituted 1,2-dioxetanes
12/14/1999US6001561 Indicator reagents for assays using chemiluminescent electron-rich aryl substituted 1,2-dioxetanes
12/14/1999US6001389 Compositions containing biologically active silicon
12/09/1999WO1999062968A1 Supported group 8-10 transition metal olefin polymerization catalysts